plasticity. In contrast, alpha-2 receptor stimulation often impairs stimulus processing and plasticity. This review provides a very brief synopsis of this research.
Arousal NE profoundly modulates the state of alertness through a variety of actions, many of which involve stimulation of beta adrenergic receptors. Beta adrenergic receptor stimulation in the cortex produces an awake state by potently blocking spike frequency adaptation by reducing a potassium current, Iav (reviewed in McCormick et al., 1991) . In the thalamus, application of NE suppresses rhythmic burst activity and switches neurons to a single-spike firing mode, capable of transmitting information. This effect reflects a beta receptor-mediated enhancement of a hyperpolarization-activated cation current, IH, and an alpha-1 receptor-mediated suppression of a resting leak potassium current, IKL (ibid). Buzsaki and colleagues (1991) have shown that stimulation of alpha-1 receptors in the thalamus elicits an alert state, whereas stimulation of postsynaptic alpha-2 receptors produces sedation. Activation of the EEG in the cortex and hippocampus can also be produced by beta adrenergic stimulation in the medial septal nucleus (Beridge et al., 1996; Berridge & Foote, 1996) .
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Stimulus processing
It has long been appreciated that NE enhances the "signal/noise" processing of sensory stimuli (Foote et al., 1975; Segal & Bloom, 1976; Waterhouse et al., 1998) . Waterhouse and colleagues (Waterhouse et al., 1980; Waterhouse et al., 1981 ; Mouradian et al., 1991) Beta receptor stimulation plays a critical role in long-term memory consolidation, particularly in the amygdala. Memory enhancement by emotional events is thought to occur through epinephrine release in the periphery and through beta adrenergic receptor stimulation in the amygdala (reviewed in Cahill & McGaugh, 1996) . Thus, infusion of beta adrenergic antagonists into the amygdala impairs long-term memory consolidation, whereas infusion of a beta adrenergic agonist improves memory consolidation (ibid). Recent findings suggest that alpha-1 adrenergic mechanisms may facilitate beta adrenergic effects (Ferry et al., 1999) . In contrast, alpha-2 receptor stimulation impairs memory consolidation, and the alpha-2 agonist, clonidine, is used as an amnestic agent in basic research (Genkova-Papazova et al., 1997) .
Beta adrenergic mechanisms also contribute to memory consolidation in the hippocampus.
For example, it has long been appreciated that NE enhances long-term potentiation (LTP) in the mossy fiber-CA3 synapse, via a beta adrenergic mechanism (Hopkins & Johnston, 1988) . Indeed, beta receptor stimulation in the dentate gyrus can actually induce LTP, even in the absence of highfrequency stimulation (Lacaille & Harley, 1985; Bramhan et al., 1997; Chaulk & Harley, 1998) .
Alpha-1 receptor stimulation appears to contribute as well, although these effects are not as long lasting (Chaulk & Harley, 1998) . Beta adrenergic stimulation appears to be particularly important for the late phase of memory consolidation (Roullet & Sara, 1998; Sara et al., 1999) (Ardenghi et al., 1997) . Alpha-1 adrenergic mechanisms appear to have a weaker, but nonetheless beneficial, effect on memory consolidation (Puumala et al., 1998) and on long-term potentiation in the hippocampus (Pussinen & Sirvi6, 1998 (Kirkwood et al., 1999 stimulation, and are impaired by alpha-1 receptor stimulation. Thus, the neurochemical needs of the PFC appear to be "upside down and backwards" from that ofthe rest ofthe brain (Fig. 1 ).
PFC functions
The PFC expands greatly in primates and is critical for guiding behavior, using working memory (Goldman-Rakic, 1987) . As working memory is constantly updated, the memories may be called up from long-term storage or from more recent buffers. The PFC uses these representations to guide behavior effectively, freeing the organism from its dependence on the environment, inhibiting inappropriate responses or distractions, and allowing us to plan and organize effectively (Robbins, 1996) . The PFC regulates attention, inhibiting responses to irrelevant stimuli by gating stimulus processing in sensory cortices (Knight et al., 1989 ; Yamaguehi & Knight, 1990) and by sustaining attention to relevant stimuli, particularly over long delays (Chao & Knight, 1997; Wilkins et al., 1987) . Animals or humans with lesions to the PFC can exhibit poor attention regulation, disorganized behavior, hyperactivity, and impulsivity (Stuss et al., 1994 (Amsten & Goldman-Rakic, 1985) nor intra-PFC infusion (Li & Mei, 1994) of the beta adrenergic antagonist, propranolol, alters working memory performance in monkeys. Similarly, infusion of the beta adrenergic agonist, isoproterenol (0.1 tg/0.5BL) into the medial PFC in rats has no effect on working memory performance in a T maze (Fig. 2) . More detailed studies with selective beta 1 or beta 2 agents may produce different results, but current evidence suggests little involvement of beta adrenoceptor mechanisms in PFC function.
Alpha-2 adrenergic mechanisms
Although beta adrenergic receptors appear to have little influence on working memory, stimulation of post-synaptic alpha-2 adrenergic receptors has marked beneficial effects on PFC function (Fig. 3) . Alpha-2-adrenoceptor agonists, such as clonidine, guanfacine, or meditomidine, administered either systemically (Amsten & Goldman-Rakic, 1985; Amsten et al., 1988; Carlson et al., 1992; Rama et al., 1996; Franowicz & Amsten, 1998) (Amsten & GoldmanRakic, 1985; Li & Mei, 1994) . Thus, intra-PFC infusion of an alpha-2, but not a beta or alpha-1 antagonist, produces a delay-related impairment in working memory performance in monkeys (Li & Mei, 1994) . Evidence indicates that alpha-2 agents alter working memory through actions at post-synaptic alpha-2 receptors. For example, alpha-2 agonists are more potent and more efficacious in animals with catecholamine depletion (Amsten & Goldman-Rakic, 1985; Cai et al., 1993) .
Evidence also suggests that the alpha-2A receptor subtype is likely to be the receptor underlying beneficial effects on working memory, from pharmacological profiles (Amsten et al., 1988; Amsten & Leslie, 1991; Rama et al., 1996) , and from results in mice with genetically altered alpha-2 receptors Tanila et al., 1999 (Jackson & Buccafusco, 1991; Amsten & Contant, 1992) .
The importance of drug actions in the PFC for working memory enhancemem has recently been confirmed in electrophysiological studies of monkeys performing working memory tasks.
Delay-related firing, namely, an increased rate of firing during the delay period relative to spontaneous activity, is thought to reflect the cellular basis of working memory function (Funahashi et al., 1989) . Iontophoresis of the alpha-2 antagonist, yohimbine, onto PFC neurons reduces delay-related firing (Sawaguchi, 1998; Li et al., 1999 Accumulating evidence indicates that the beneficial effects of alpha-2 agonists on PFC function in animals extend to humans as well.
Earlier literature showed that the alpha-2 agonist, elonidine, could improve PFC deficits in patients with Korskoff's amnesia (Mair & McEntree, 1986) (Haroutunian et al., 1990) . The effects of clonidine in healthy young adults have been more complex. Higher doses that are thought to improve PFC function were often not given to normal individuals because of problematic side effects, and studies using lower clonidine doses have shown mixed effects on cognitive function (Coull, 1994; Coull et al., 1995; Jakala et al., 1999a; Jakala et al., 1999b (Jakala et al., 1999a; Jakala et al., 1999b) . Guanfacine has been shown to improve ADHD symptoms and PFC task performance in both open label (Chappell et al., 1995; Horrigan & Bamhill, 1995; Hunt et al., 1995) and controlled trials (F. Taylor, personal communication; L. Scahill, personal communication) , and is now being tested in other PFC cognitive disorders. Thus, alpha-2A receptor stimulation may have therapeutic effects in disorders with PFC cognitive deficits.
Alpha-1 adrenergic mechanisms
In contrast to the beneficial effects of alpha-2 receptors, recent studies suggest that alpha-1 adrenoceptor stimulation markedly impairs PFC function. In rats, infusions of the alpha-1 agonist, phenylephrine, into the PFC produced large deficits in working memory performance ( Fig. 2 ; Amsten et al., 1999) . This impairment was reversed by the co-infusion of the alpha-1 receptor antagonist, urapidil, consistent with actions at alpha-1 receptors. Similar effects have been observed in monkeys performing the delayed response task, a test of spatial working memory that is dependent on the dorsolateral PFC surrounding the principal sulcus . Infusions of phenylephrine produced a delay-related impairment in working memory performance. Infusions were most effective in the caudal two-thirds of the principal sulcal cortex (ibid), the cortical region most tightly associated with spatial working memory performance in monkeys (Goldman & Rosvold, 1970 (Duman & Nestler, 1995) , and evidence to date suggests that alpha-1 receptor stimulation impairs PFC function through the activation of this second messenger pathway. For example, the cognitive impairment induced by phenylephrine infusions into the rat PFC can be completely reversed by pretreatment with a dose of lithium, known to suppress phosphotidyl inositol turnover (Amsten et al., 1999) . These data may have special relevance to bipolar disorder, a disorder commonly treated with lithium and associated with increased NE turnover. Lithium, however, can alter other second messenger pathways; thus, current studies in animals are focusing on agents that selectively target molecules in the phosphotidyl inositol/ PKC cascade. For example, intra-PFC infusion of the PKC inhibitor, chelerythrine, appears to block the detrimental effects of alpha-1 agonists (S. Bimbaum & A. Amsten, unpublished Amsten & Goldman-Rakic, 1998) . Although most of this research has focused on the role of high levels of dopamine-receptor stimulation in the stress response, NE is also released in the PFC during stress exposure (Finlay et al., 1995; Goldstein et al., 1996) . Recent results demonstrate that NE alpha-1 receptor mechanisms also contribute to stress-induced working memory deficits, as intra-PFC infusion of the alpha-1 antagonist, urapidil, protected performance from the detrimental effects of stress (Bimbaum et al., 1999) . It is likely that during stress exposure, NE and dopamine mechanisms synergize to take the PFC "off-line". Recent results suggest that dopamine may impair working memory performance via the activation of D1 receptors (Zahrt et al., 1997) that are coupled to the cAMP/PKA pathway (Taylor et al., 1999 (Amsten, 1998; Amsten & Goldman-Rakic, 1998 ). Studies of the effects of stress on higher cognitive functioning in humans have illustrated that many of the cognitive abilities that are now associated with the PFC are impaired by exposure to stress (Hockey, 1970; Broadbent, 1971; Hartley & Adams, 1974) , particularly when the subject feels no control over the stressor (for example see Glass et al., 1971 ), whereas highly trained or prepotent responses can actually improve with stress (Broadbent, 1971) . Possibly, many of these changes in performance during stress result from increased catecholamine release during stress exposure. Increased catecholamine release during stress is thought to be triggered by the amygdala, which projects to the catecholamine cells (Goldstein et al., 1996) . Increased catecholamine release during stress may enhance the functions of the posterior cortices and many subcortical areas through actions at beta and/or alpha-1 receptors, while impairing prefrontal cortical function through actions at alpha-1 receptors. For example, increased catcholamine release during stress would enhance our long-term memory of an aversive event so that we might avoid it in the future, and this enhanced memory consolidation would likely involve increased beta-receptor stimulation in the amygdala (Cahill et al., 1994) and in the hippocampus (Packard & Teather, 1998) . Increased catecholamine release during stress might also alter attentional regulation, allowing attention to be "captured" by prominent stimuli in the environment. For example, in his study of humans exposed to loud noise stress, Hockey (1970) showed that stress (a) narrows the focus of attention onto salient signals, but (b) makes attention more labile (namely, impaired ability to sustain attention). These changes in attentional regulation may occur by (a)beta/ alpha-1 receptor enhancement of signal processing in sensory cortices, and (b)alpha-1 receptor impairment of PFC, respectively. This hypothesis is consistent with the affinity of NE for the adrenergic receptors (Fig. 4) (Mohell et al., 1983) or beta receptors (Pepperl & Regan, 1994 (Mazure, 1995 
